Your browser doesn't support javascript.
loading
Mutational Landscape of Ovarian Adult Granulosa Cell Tumors from Whole Exome and Targeted TERT Promoter Sequencing.
Alexiadis, Maria; Rowley, Simone M; Chu, Simon; Leung, Dilys T H; Stewart, Colin J R; Amarasinghe, Kaushalya C; Campbell, Ian G; Fuller, Peter J.
Affiliation
  • Alexiadis M; Hudson Institute of Medical Research and Monash University Department of Molecular Translational Science, Clayton, Victoria, Australia.
  • Rowley SM; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Chu S; Hudson Institute of Medical Research and Monash University Department of Molecular Translational Science, Clayton, Victoria, Australia.
  • Leung DTH; Hudson Institute of Medical Research and Monash University Department of Molecular Translational Science, Clayton, Victoria, Australia.
  • Stewart CJR; Department of Histopathology, King Edward Memorial Hospital, Perth, Australia.
  • Amarasinghe KC; The School for Women's and Infants' Health, University of Western Australia, Crawley, Western Australia, Australia.
  • Campbell IG; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Fuller PJ; Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.
Mol Cancer Res ; 17(1): 177-185, 2019 01.
Article in En | MEDLINE | ID: mdl-30166312
Adult granulosa cell tumor (aGCT), the most common malignant ovarian sex cord-stromal tumor, is characterized by the forkhead transcription factor FOXL2 p.C134W somatic mutation. Late recurrences are relatively common but the molecular mechanisms of relapse or aggressive behavior are not known. The mutational landscape of FOXL2 p.C134W mutation-positive tumors (n = 22) was determined using whole-exome sequencing (WES). An average of 64 coding and essential splice-site variants were identified per tumor. As the TERT promoter region is poorly covered by the WES, targeted sequencing identified the TERT -124C>T promoter mutation as the only recurrent mutation (∼40% of cases). Pathway analysis suggested an association with DNA replication/repair and the EGFR family canonical pathways. Copy number analysis confirmed that gains of chromosomes 12 and 14 occur in approximately 30% of aGCT and loss of chromosome 22 occurs in approximately 40% of cases. In summary, exome-wide analysis of the mutational landscape of aGCT revealed that, except for the TERT promoter mutation, recurrence and/or aggressive behavior is not defined by activation or loss of specific genes. IMPLICATIONS: This study found that although aGCTs are defined by the presence of a common FOXL2 gene mutation, recurrence and/or aggressive behavior cannot be attributed to subsequent mutation of specific gene(s) or pathways; however, there is a high frequency of the TERT -124C>T promoter mutation, which is associated with more aggressive disease.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Telomerase / Exome / Granulosa Cell Tumor / Mutation Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Australia Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Telomerase / Exome / Granulosa Cell Tumor / Mutation Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Australia Country of publication: United States